Vimarsana
Biggest News Aggregation in the World

Page 5 - Expanded Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expanded Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expanded Access Program Today - Breaking & Trending Today

RedHill Biopharma Announces $8 Million Registered Direct Offering - Vimarsana News

RedHill Biopharma Announces $8 Million Registered Direct Offering

Published: January 25, 2024

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered...

Source: prnewswire.com
Related Topics:
United KingdomNew YorkUnited StatesAdi FrishRedhill BiopharmaCompany American Depositary Shares AdssCompany Expanded Access ProgramPrnewswire Redhill Biopharma LtdRedhill Biopharma LtdCompany Annual Report On FormExchange CommissionProduct Development PipelineHc Wainwright CoCorporate Business DevelopmentHill BiopharmaAmerican Depositary SharesSecurities ActAcute Radiation SyndromePrivate Securities Litigation Reform ActNasdaq Capital MarketDevelopment PipelineExpanded Access ProgramAnnual ReportRedhill Biopharma LtdHealth Care Amp Hospitals
Zevra Therapeutics Appoints Global Medical Leader, Adrian - Vimarsana News

Zevra Therapeutics Appoints Global Medical Leader, Adrian

Published: January 4, 2024

CELEBRATION, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics...

Source: globenewswire.com
Related Topics:
City OfUnited KingdomIgnacio Guerrero RosDavid SchullNeilf McfarlaneNichol OchsnerZevra Therapeutics IncCompensation Committee Of Zevra Board DirectorsCompany Expanded Access ProgramGroup ViceErasmus University Medical CenterAdamas PharmaceuticalsErasmus University Medical SchoolGlobal Medical Affairs At Biomarin Pharmaceuticals IncExchange CommissionClinical ResearchAdrian QuartelChief MedicalAcer TherapeuticsChief Executive OfficerChief Medical OfficerGroup Vice PresidentGlobal Medical AffairsBiomarin Pharmaceuticals IncErasmus University Medical
RedHill Biopharma : and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola - Form 6-K -December 20, 2023 at 08:58 am EST - Vimarsana News

RedHill Biopharma : and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola - Form 6-K -December 20, 2023 at 08:58 am EST

Published: December 20, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...

Source: marketscreener.com
Related Topics:
Macau GeneralUnited StatesCoted IvoireHong KongUnited KingdomTel AvivSouth AfricaIvory CoastDror Ben AsherJeffrey KugelmanReza FathiRedhill BiopharmaAdi FrishUs Department Of DefenseGilead Sciences IncUs Army EbolaCommission File NoGermany Heidelberg PharmaceuticalsExchange Commission OnCenters For DiseaseCompany Annual Report On FormProduct Development PipelineCorporate Business DevelopmentCompany Expanded Access ProgramNational Institutes Of Health
Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab in Multiple Sclerosis - Vimarsana News

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab in Multiple Sclerosis

Published: December 19, 2023

19.12.2023 - NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) - Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough neuro-immunomodulation therapies, today announced “first patient dosed” in its Phase ... Seite 1

Source: wallstreet-online.de
Related Topics:
Gabriele CerroneMattheww DavisTanuja ChitnisTiziana Life Sciences LtdAccess ProgramTiziana Life SciencesProfessor Of Neurology At Harvard Medical SchoolLife SciencesExpanded Disability Status ScaleModified Fatigue Impact ScalePrincipal InvestigatorMass General Brigham Healthcare SystemHarvard MedicalExpanded Access ProgramChief Operating OfficerChief Medical OfficerTiziana Life Sciences ChartIziana Life Sciences KursIziana Life Sciences Aktie
RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement - Vimarsana News

RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

Published: December 12, 2023

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it received...

Source: prnewswire.com
Related Topics:
United KingdomUnited StatesAdi FrishRedhill BiopharmaCompany Expanded Access ProgramNasdaq Listings Qualifications DepartmentRedhill Biopharma LtdNasdaq Stock MarketExchange CommissionCompany Annual Report On FormCorporate Business DevelopmentProduct Development PipelineNasdaq Listing RuleAmerican Depositary SharesHill BiopharmaAcute Radiation SyndromePrivate Securities Litigation Reform ActNasdaq Capital MarketDevelopment PipelineExpanded Access ProgramAnnual ReportRedhill Biopharma Ltd